Saskia de Wildt and colleagues, theme Renal disorders, obtained an EU Horizon 2020 grant of € 123.000 for a new research infrastructure that will facilitate the future development of better paediatric medicines.Children and young people represent 20 % of the European population. When we refer to this group of people as patients, it’s essential to consider that they are different from the adult patients. Their metabolism is different, because they are in continuous development and also they can suffer diseases that sometimes might be limited to the paediatric setting.Taking into consideration these specificities, the need of treatments addressed only for children is a public priority. Nowadays around 50% of the medicines that are prescribed to paediatric patients have not been tested specially for them. For this reason, it is essential to promote and increase paediatric research.
The translation between bench to the bedside requires the involvement of different expert research groups in drug early discovery, biomarkers, formulation, pharmacology, etc. that already collaborate in Europe within the already existing research infrastructures. But the problem is that they do not are specifically dedicated to research in children.The time needed for the development of new medicines is also an important concern. It is long, from the basic research (before the study of a potential treatment with humans) to the clinical research (when we study this potential treatment with patients). It can also take among 7-10 years from the screening of new molecules to the market of a new drug and the average of success rate is really low (1 over 10.000 molecules studied). For this reason, it's essential to join efforts and work in a collaborative way between the European experts groups that at this moment are working to develop paediatric medicines.
ID-EPTRI is a project funded by the European Commission that has as main objective to design the framework for the European Paediatric Translational Research Infrastructure (EPTRI). A research infrastructure is a set of facilities, resources and related services at disposal of the scientific community to conduct top-level research. EPTRI will be a new research infrastructure that will integrate the paediatric expertise of five different areas of pre-clinical research: early discovery and preclinical studies, biomarkers, pharmacology, formulation and underpinning paediatric studies. The main objective of ID-EPTRI is to facilitate the paediatric pre-clinical research while reducing the time of its translation to the clinical phase.
The project involves 26 partners from EU and non-EU countries including already existing research infrastructures, top-level universities, scientific and clinical centers of excellence in Europe. It is coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF), a not-for-profit organization, founded in 2000 with the mission to perform research and provide scientific, economic and regulatory consultancy for innovation in the health sector at European level.
Saskia de Wildt, project leader, is member of the theme Renal disorders.
Related news items
Prinses Beatrix Spierfonds grant to investigate patient stratification in myotonic dystrophy24 January 2020
Rick Wansink and Roland Brock, both theme Nanomedicine, received a € 280,000 grant from the Prinses Beatrix Spierfonds.read more
RIMLS PhD retreat registration is open23 January 2020
Yearly, RIMLS PhD candidates gather for the two-day PhD Retreat. Apart from the science, this event is highly valued for the opportunity to meet and get to know fellow PhD candidates during the social activities. Early bird registration and abstract submission deadline: 4 March 2020.read more
Cognitive behavioral therapy reduces severe fatigue in patients with advanced cancer during treatment23 January 2020
In Annals of Oncology, RIHS researchers Hanneke Poort, Marlies Peters, Winette van der Graaf, Ria Nijhuis van der Sanden and colleagues showed significant effects of cognitive behavioral therapy on fatigue in patients with advanced cancer during treatment with palliative intent.read more
6 million euros to uncover link between metabolic and brain disorders21 January 2020
An important European-funded initiative, coordinated by Radboudumc researchers Barbara Franke, Jan Buitelaar, and Janita Bralten, has been launched to explore how common molecular mechanisms may link metabolic disorders with brain disorders.read more
NWO Open Competition Domain Science - XS grant for Ronald van Rij and Jenny van der Wijst21 January 2020
NWO Domain Science has awarded Ronald van Rij, theme Infectious diseases and global health and Jennny van der Wijst, theme Renal disorders an XS grant. The XS category emphatically strives to encourage curiosity-driven and bold research involving a relatively quick analysis of a promising idea.read more